Literature DB >> 26228456

Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions.

Danny Riethorst1, Raf Mols1, Guus Duchateau2, Jan Tack3, Joachim Brouwers1, Patrick Augustijns4.   

Abstract

This work provides an elaborate characterization of human intestinal fluids (HIF) collected in fasted- and fed-state conditions. HIF from 20 healthy volunteers (10 M/F) were aspirated by intubation near the ligament of Treitz in a time-dependent manner (10-min intervals) and characterized for pH, bile salts, phospholipids, cholesterol, triacylglycerides (TAG), diacylglycerides (DAG), monoacylglycerides (MAG), free fatty acids (FFA), pancreatic lipase, phospholipase A2, and nonspecific esterase activity. For almost all parameters, a food-induced effect was observed. Results were characterized by a high variability, as illustrated by the broad ranges observed for each parameter: pH (fasted: 3.4-8.3; fed: 4.7-7.1), bile salts (fasted: 0.03-36.18 mM; fed: 0.74-86.14 mM), phospholipids (fasted: 0.01-6.33 mM; fed: 0.16-14.39 mM), cholesterol (fasted: 0-0.48 mM; fed: 0-3.29 mM), TAG (fed: 0-6.76 mg/mL), DAG (fed: 0-3.64 mg/mL), MAG (fasted: 0-1.09 mg/mL; fed: 0-11.36 mg/mL), FFA (fasted: 0-3.86 mg/mL; fed: 0.53-15.0 mg/mL), pancreatic lipase (fasted: 26-86 g/mL; fed: 146-415 g/mL), phospholipase A2 (fasted: 3-6 ng/mL; fed: 4.3-27.7 ng/mL), and nonspecific esterase activity (fasted: 270-4900 U/mL; fed: 430-4655 U/mL). This comprehensive overview may serve as reference data for physiologically based pharmacokinetic modeling and the optimization of biorelevant simulated intestinal fluids for the use in in vitro dissolution, solubility, and permeability profiling.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  food effects; gastrointestinal; intestinal drug absorption; intestinal secretion; lipids; oral drug delivery; pH; phospholipids

Mesh:

Substances:

Year:  2016        PMID: 26228456     DOI: 10.1002/jps.24603

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  29 in total

1.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

2.  Assessing bioequivalence of generic modified-release antiepileptic drugs.

Authors:  Emily L Johnson; Yi-Ting Chang; Barbara Davit; Barry E Gidal; Gregory L Krauss
Journal:  Neurology       Date:  2016-03-25       Impact factor: 9.910

3.  Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.

Authors:  Anura S Indulkar; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2018-06-18       Impact factor: 4.200

4.  Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.

Authors:  Anura S Indulkar; Huaping Mo; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-03-28       Impact factor: 4.200

Review 5.  The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Authors:  Om Anand; Xavier J H Pepin; Vidula Kolhatkar; Paul Seo
Journal:  Pharm Res       Date:  2022-05-18       Impact factor: 4.580

6.  Drug disposition before and after gastric bypass: fenofibrate and posaconazole.

Authors:  Ina Gesquiere; Bart Hens; Bart Van der Schueren; Raf Mols; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Veerle Foulon; Patrick Augustijns
Journal:  Br J Clin Pharmacol       Date:  2016-07-25       Impact factor: 4.335

7.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

8.  In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance.

Authors:  Yasuhiro Tsume; Sanjaykumar Patel; Nikoletta Fotaki; Christel Bergstrӧm; Gordon L Amidon; James G Brasseur; Deanna M Mudie; Duxin Sun; Marival Bermejo; Ping Gao; Wei Zhu; David C Sperry; Maria Vertzoni; Neil Parrott; Robert Lionberger; Atsushi Kambayashi; Andre Hermans; Xujin Lu; Gregory E Amidon
Journal:  AAPS J       Date:  2018-09-06       Impact factor: 4.009

9.  Partitioning into Colloidal Structures of Fasted State Intestinal Fluid Studied by Molecular Dynamics Simulations.

Authors:  Michael Holmboe; Per Larsson; Jamshed Anwar; Christel A S Bergström
Journal:  Langmuir       Date:  2016-11-28       Impact factor: 3.882

10.  Altered duodenal bile salt concentration and receptor expression in functional dyspepsia.

Authors:  Dorien Beeckmans; Danny Riethorst; Patrick Augustijns; Tim Vanuytsel; Ricard Farré; Jan Tack; Hanne Vanheel
Journal:  United European Gastroenterol J       Date:  2018-09-04       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.